Age-related inflammatory changes: The role of genes and body composition changes
年龄相关的炎症变化:基因的作用和身体成分的变化
基本信息
- 批准号:7123714
- 负责人:
- 金额:$ 32.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:C reactive proteinatherosclerosisbiomarkerbody compositioncardiovascular disorder riskclinical researchgenetic susceptibilitygenotypehuman datahuman subjectimmune responseimmunogeneticsimmunosenescenceinflammationinterleukin 6longitudinal human studyobesitysingle nucleotide polymorphismstatistics /biometry
项目摘要
DESCRIPTION (provided by applicant): This proposal aims to quantify the effects of inflammatory genes and body composition changes on age-related changes in inflammatory markers. Inflammation has been implicated in a number of diseases and conditions that affect older adults including atherosclerotic cardiovascular disease (ASCVD). Inflammatory activity increases with aging, however, the knowledge about the natural history of this change and its origins and consequences is extremely limited. We postulate that age-related changes in inflammatory markers are partially explained by age-related changes in adiposity and inflammatory gene polymorphisms, and may be an important risk factor for subsequent ASCVD. Longitudinal data analyses using the Health Aging and Body Composition (Health ABC) Study, a prospective study of 3,075 black and white, men and women in their seventies who have been followed annually since 1997-98, will allow us to efficiently achieve the following specific aims: 1) to determine the pattern of changes in inflammatory markers with age during 7 years of follow-up; 2) to test the extent to which observed changes in inflammatory markers can be attributed to increase in fat mass or visceral fat and inflammatory gene polymorphisms; 3) to determine the predictive ability of age-related changes in inflammatory markers on subsequent ASCVD events. The proposed study will include all the Health ABC participants. For aim1 and 2, we will conduct measures of serum C-reactive protein and interleukin-6 levels every two years and sequence variants of approximately 29 important genes involved in inflammation and innate immune response. We will perform longitudinal data analyses using linear mixed-effect models. For aim 3, a prospective analysis will be conducted with Cox proportional hazard model. Understanding age-related alterations in immunosenescence and its cardiovascular deterioration is becoming increasingly important and may provide the basis for therapeutic interventions that will impact not only risk of ASCVD, but will impact morbidity and mortality from other common diseases of the elderly such as diabetes, dementia, frailty and disability. The Health ABC study, the only large cohort of community-dwelling older adults with long term follow-up and annually detailed measures of body composition, along with a wide range of functional, clinical, and laboratory data, provides a unique opportunity for studying this area of high scientific priority.
描述(由申请人提供):本提案旨在量化炎症基因和身体组成变化对炎症标志物年龄相关变化的影响。炎症与许多影响老年人的疾病和病症有关,包括动脉粥样硬化性心血管疾病(ASCVD)。炎症活动随着年龄的增长而增加,然而,关于这种变化的自然历史及其起源和后果的知识非常有限。我们推测,与年龄相关的炎症标志物的变化部分是由肥胖和炎症基因多态性的年龄相关变化解释的,并且可能是随后ASCVD的重要危险因素。使用健康老化和身体成分的纵向数据分析(Health ABC)研究,一项对3,075名70多岁的黑人和白色男性和女性的前瞻性研究,自1997-98年以来每年随访一次,将使我们有效地实现以下具体目标:1)确定7年随访期间炎症标志物随年龄变化的模式; 2)测试观察到的炎症标志物变化可归因于脂肪量或内脏脂肪增加和炎症基因多态性的程度; 3)确定炎症标志物年龄相关变化对随后ASCVD事件的预测能力。拟议的研究将包括所有健康ABC参与者。对于aim 1和aim 2,我们将每两年测量一次血清C反应蛋白和白细胞介素-6水平,以及参与炎症和先天免疫反应的大约29个重要基因的序列变体。我们将使用线性混合效应模型进行纵向数据分析。对于目标3,将采用考克斯比例风险模型进行前瞻性分析。了解年龄相关的免疫衰老及其心血管恶化的变化正变得越来越重要,并可能为治疗干预提供基础,这些干预不仅会影响ASCVD的风险,而且会影响老年人其他常见疾病(如糖尿病,痴呆,虚弱和残疾)的发病率和死亡率。健康ABC研究是唯一一项对社区居住的老年人进行长期随访和每年详细测量身体成分的大型队列研究,沿着了广泛的功能、临床和实验室数据,为研究这一高度科学优先领域提供了独特的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONGMEI LIU其他文献
YONGMEI LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONGMEI LIU', 18)}}的其他基金
Common mechanistic biomarkers of vascular and neuro-degeneration
血管和神经变性的常见机制生物标志物
- 批准号:
10567120 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Trajectories of blood-based biomarkers of AD, their determinants, and ability to predict cognitive impairment
AD 血液生物标志物的轨迹、其决定因素以及预测认知障碍的能力
- 批准号:
10670494 - 财政年份:2022
- 资助金额:
$ 32.34万 - 项目类别:
Obesity-Related Epigenetic Changes and Type-2 Diabetes
肥胖相关的表观遗传变化和 2 型糖尿病
- 批准号:
9928648 - 财政年份:2019
- 资助金额:
$ 32.34万 - 项目类别:
A Longitudinal Epigenetic Study of Atherosclerosis
动脉粥样硬化的纵向表观遗传学研究
- 批准号:
9217955 - 财政年份:2016
- 资助金额:
$ 32.34万 - 项目类别:
DNA METHYLATION AND GENE EXPRESSION PROFILES IN MONOCYTES
单核细胞中的 DNA 甲基化和基因表达谱
- 批准号:
8167061 - 财政年份:2010
- 资助金额:
$ 32.34万 - 项目类别:
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis
DNA 甲基化与动脉粥样硬化的全表观基因组关联研究
- 批准号:
8517176 - 财政年份:2009
- 资助金额:
$ 32.34万 - 项目类别:
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis
DNA 甲基化与动脉粥样硬化的全表观基因组关联研究
- 批准号:
7727328 - 财政年份:2009
- 资助金额:
$ 32.34万 - 项目类别:
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis
DNA 甲基化与动脉粥样硬化的全表观基因组关联研究
- 批准号:
7932747 - 财政年份:2009
- 资助金额:
$ 32.34万 - 项目类别:
相似国自然基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
- 批准号:91957111
- 批准年份:2019
- 资助金额:80.0 万元
- 项目类别:重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
- 批准号:81170251
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
- 批准号:81000086
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
- 批准号:81070247
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
- 批准号:30971216
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
- 批准号:30871040
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
- 批准号:
10733384 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Investigating relationships between naturalistic light exposure and sleep
研究自然光照与睡眠之间的关系
- 批准号:
10739430 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Common mechanistic biomarkers of vascular and neuro-degeneration
血管和神经变性的常见机制生物标志物
- 批准号:
10567120 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Integration of single-cell imaging and multi-omics sequencing to study EC mechano-pathophysiology
整合单细胞成像和多组学测序来研究 EC 机械病理生理学
- 批准号:
10825307 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Wisconsin Registry for Alzheimer's Prevention
威斯康星州阿尔茨海默病预防登记处
- 批准号:
10655978 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Microvascular Neuroimaging in Age-related Alzheimer's Disease and Tauopathies
年龄相关性阿尔茨海默病和 Tau蛋白病的微血管神经影像学
- 批准号:
10738372 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
IDO1 regulation of SR-BI and cholesterol homeostasis in macrophages
IDO1 对巨噬细胞中 SR-BI 和胆固醇稳态的调节
- 批准号:
10731003 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别: